Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil PCIA after laparoscopic colorectal cancer surgery
ChiCTR2500105354Phase 4Not yet recruiting
- Sponsor
- Gansu Provincial People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (4 arms), sponsored by Gansu Provincial People's Hospital. Primary endpoint: Postoperative NRS pain score. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500105354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105354.